MDM2 SNP309 variation contributes to leukemia risk: meta-analyses based on 7259 subjects
Zhuo W, Zhang L, Ling J, Zhu B, Chen Z
Record Status
This is a systematic review that meets the criteria for inclusion on DARE.
Bibliographic details
Zhuo W, Zhang L, Ling J, Zhu B, Chen Z. MDM2 SNP309 variation contributes to leukemia risk: meta-analyses based on 7259 subjects. Leukemia and Lymphoma 2012; 53(11): 2245-2252
PubMedID
22563815
DOI
10.3109/10428194.2012.691485
Original Paper URL
http://informahealthcare.com/doi/abs/10.3109/10428194.2012.691485
Indexing Status
Subject indexing assigned by NLM
MeSH
Alleles; Genotype; Humans; Leukemia /etiology /genetics; Polymorphism, Single Nucleotide; Proto-Oncogene Proteins c-mdm2 /genetics; Publication Bias; Risk
AccessionNumber
12012048080
Date bibliographic record published
20/12/2012
Database of Abstracts of Reviews of Effects (DARE)
Produced by the Centre for Reviews and Dissemination
Copyright © 2024 University of York
Homepage
Options
Print
PDF
PubMed record
Original research
Share
Message for DARE database users